Previously lecanemab was only approved as an SC injection for maintenance dosing, following an initial 18 month IV phase.

Synjardy and Synjardy XR are prescription medications used with diet and exercise to lower blood sugar in adults with type 2 diabetes and reduce the risk of death from heart attack and stroke in those ...

The FDA has delivered a gift to Novo Nordisk ahead of the holiday season, with the prompt approval of an oral formulation of its blockbuster weight-loss therapy Wegovy. The green light for the first ...

Rishika leads Reuters’ coverage of India’s pharmaceutical and healthcare sector. Her reporting focuses on key themes such as the emergence of weight-loss drugs, the country’s drug regulatory framework ...